Related Experiment Video
Updated: Jul 31, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories
Davide Placido1, Bo Yuan2,3,4, Jessica X Hjaltelin1
1Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Artificial intelligence accurately predicts pancreatic cancer risk using patient health records. This early detection method identifies high-risk individuals, potentially improving survival rates for this aggressive disease.
Area of Science:
- Oncology
- Medical Informatics
- Artificial Intelligence
Background:
- Pancreatic cancer presents late, leading to poor patient outcomes.
- Early detection is crucial for improving survival and quality of life.
- Current diagnostic methods have limitations in identifying at-risk individuals proactively.
Purpose of the Study:
- To develop and validate artificial intelligence (AI) models for predicting pancreatic cancer risk.
- To assess the performance of AI models using large-scale clinical datasets from Denmark and the US.
- To evaluate the feasibility of implementing AI-driven surveillance programs for early pancreatic cancer detection.
Main Methods:
- Machine learning models were trained on sequential disease codes from electronic health records.
- Data from the Danish National Patient Registry (DNPR) and US Veterans Affairs (US-VA) databases were utilized.
- Model performance was evaluated using the area under the receiver operating characteristic (AUROC) curve for predicting cancer occurrence within various time windows.
Main Results:
- The best model trained on Danish data achieved an AUROC of 0.88 for predicting cancer within 36 months.
- Excluding recent disease events (3 months prior) reduced performance to AUROC 0.83.
- The model identified a relative risk of 59 for the highest-risk group (over 50 years old).
- Cross-application to US data showed lower AUROC (0.71), necessitating model retraining for improved performance (AUROC 0.78).
Conclusions:
- AI models demonstrate significant potential for early pancreatic cancer risk prediction.
- These models can inform the design of targeted surveillance programs for high-risk populations.
- Early detection through AI can potentially enhance patient lifespan and quality of life.
More Related Videos
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018